Skip to main content
Toggle navigation
Login
Search
Home
Tweets by ISEV2025 Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Poster Schedule
Home
Poster Schedule
All Days
Thu, Apr 24
Fri, Apr 25
Poster Schedule
Type here to filter the list
Thursday, April 24, 2025
12:00 – 14:30
CET
(136) EVs from glycolytic MSCs: a promising therapy for osteoarthritis
Favorite
12:00 – 14:30
CET
(171) Microalgae-Derived Extracellular Vesicles as a Next-Generation Platform for Bone Health Treatments
Favorite
12:00 – 14:30
CET
(579) Exosomes derived from bone marrow mesenchymal stem cells alleviate neurovascular dysfunction following ischemic stroke injury
Favorite
12:30 – 14:30
CET
(1) The unreferenced transcriptome as source of robust biomarkers of prostate cancer in urinary extracellular vesicles
Favorite
12:30 – 14:30
CET
(2) Immunomodulatory potential of extracellular vesicles from Trichinella spiralis muscle larvae
Favorite
12:30 – 14:30
CET
(3) Delivery of apelin loaded extracellular vesicle for the treatment of pulmonary arterial hypertension
Favorite
12:30 – 14:30
CET
(4) Extracellular vesicles from second trimester human amniotic fluid as candidate therapeutics against skeletal and cardiac muscle injury
Favorite
12:30 – 14:30
CET
(5) Effect of EVs on systemic herpes infection in mice
Favorite
12:30 – 14:30
CET
(6) Extracellular vesicles from mesenchymal stem cells reverse neuroinflammation in cerebellum and restore motor coordination in hyperammonemic rats
Favorite
12:30 – 14:30
CET
(7) Extracellular vesicles derived from mesenchymal stem cells attenuate B cell activation
Favorite
12:30 – 14:30
CET
(8) MSC-EVs for Schwann cell modulation across multiple phases of peripheral nerve repair
Favorite
12:30 – 14:30
CET
(9) Exploring the biodistribution of p53-containing EVs for targeted cancer therapy
Favorite
12:30 – 14:30
CET
(10) Retinal transcriptome and vitreous extracellular vesicles delineating pathways involved in Retinopathy of prematurity (ROP)
Favorite
12:30 – 14:30
CET
(11) Harnessing the Angiogenic Potential of Stem Cell-Derived EVs: Therapeutic Application in a Preclinical Model of Neonatal Pulmonary Vascular Disease
Favorite
12:30 – 14:30
CET
(12) Assessment of endogenous procoagulant potential and extracellular vesicles (EVs) in thermally injured individuals
Favorite
12:30 – 14:30
CET
(13) Extracellular vesicles derived from the probiotic Propionibacterium freudenreichii modulate inflammatory response via activation of C-Jun and NFκB transcription factors in host cells
Favorite
12:30 – 14:30
CET
(14) Engineering the next generation of biologically active vascular grafts
Favorite
12:30 – 14:30
CET
(15) Efficacy of Ginger-Derived Extracellular Vesicles as a Novel Therapeutic Approach for Rheumatoid Arthritis
Favorite
12:30 – 14:30
CET
(16) A 3D model of bronchopulmonary dysplasia: GMP grade extracellular vesicles derived from human mesenchymal stromal cells reduce oxidative damage and inflammation in lung spheroids
Favorite
12:30 – 14:30
CET
(17) Enhancing the Therapeutic Potential of Hoffa MSC-Derived Extracellular Vesicles Through Differential Pre-conditioning in a Vertical Wheel Bioreactor
Favorite
12:30 – 14:30
CET
(18) Anti-inflammatory and anti-catabolic effect of EVs isolated from Hoffa´s fat pad mesenchymal stem cells on osteoarthritic chondrocytes and synovial fibroblasts
Favorite
12:30 – 14:30
CET
(19) Early Pancreatic Cancer Detection via Extracellular Vesicle-Based Classifier: A Blinded Cohort Analysis
Favorite
12:30 – 14:30
CET
(20) Tribbles Pseudokinase 3 Regulates CD276 Loading into Extracellular Vesicles in Oral Squamous Cell Carcinoma
Favorite
12:30 – 14:30
CET
(21) Cancer-associated circulating bacterial tsRNAs identified by large-scale serum RNA-seq analysis
Favorite
12:30 – 14:30
CET
(22) Time-dependent modulation of signaling pathways in melanoma spheroids by platelet-derived extracellular vesicles
Favorite
12:30 – 14:30
CET
(24) Wnt mutations change the secretome of colorectal cancer cell lines
Favorite
12:30 – 14:30
CET
(25) GABARAPL2-Alix mediate dynamic crosstalk between Autophagy and Exosome Pathways
Favorite
12:30 – 14:30
CET
(26) Annexin A2 mediated distinct small EV proteomic landscape modulates recipient cell signaling in triple-negative breast cancer
Favorite
12:30 – 14:30
CET
(27) Extracellular vesicles from temozolomide treated glioblastoma multiforme cells: insight into the morphological features and the role of bioactive cargo in the spread of cell death signals
Favorite
12:30 – 14:30
CET
(28) sEV-SDC4 play a key role in the recruitment of myeloid cells in glioblastoma
Favorite
12:30 – 14:30
CET
(29) Macrophage-mediated CD63 upregulation and extracellular vesicle secretion facilitates pancreatic cancer progression
Favorite
12:30 – 14:30
CET
(30) The invadopodia associated protease MT1-MMP is secreted on sEVs via syntenin-syndecan pathway
Favorite
12:30 – 14:30
CET
(31) Reciprocal tumour-endothelial interactions mediated by extracellular vesicles during glioblastoma progression – impact on tumour invasion, vascular morphogenesis and mobilization of immune effector cells
Favorite
12:30 – 14:30
CET
(32) Extracellular vesicle-packaged PD-L1 impedes macrophage-mediated antibacterial immunity in preexisting malignancy
Favorite
12:30 – 14:30
CET
(33) Horizontally intercellular delivery of TXNDC5 mRNA-containing small extracellular vesicles contributes to tumor-associated macrophage-mediated prostate cancer metastasis
Favorite
12:30 – 14:30
CET
(34) Multi-omics profiling demonstrates dynamic changes of cancer-associated fibroblasts and their derived extracellular vesicles during prostate cancer progression
Favorite
12:30 – 14:30
CET
(35) Role of Kindlin-2 and small extracellular vesicles in the invasion of triple negative breast cancer tumors
Favorite
12:30 – 14:30
CET
(36) Education of the bone marrow microenvironment by B-cell acute lymphoblastic leukaemia-derived large oncocosomes
Favorite
12:30 – 14:30
CET
(37) The role of platelet-derived extracellular vesicles in the formation of the lung cancer pre-metastatic niche
Favorite
12:30 – 14:30
CET
(38) Plasma-derived sEVs from HNSCC patients modulate macrophage function through NF-κB signaling
Favorite
12:30 – 14:30
CET
(39) Circulating Serum Extracellular Vesicles Proteins for Early Prediction of Platinum-Resistance in Ovarian Cancer
Favorite
12:30 – 14:30
CET
(40) The influence of Jagged ligands on the extracellular vesicles-mediated tumorigenesis in multiple myeloma
Favorite
12:30 – 14:30
CET
(41) Platelet-derived extracellular vesicles promote melanoma progression by functional changes
Favorite
12:30 – 14:30
CET
(42) Tumor extracellular vesicles promote metastasis through neutrophil mobilization and NETs formation
Favorite
12:30 – 14:30
CET
(43) Exploring extracellular vesicle dynamics in ex vivo breast cancer metastasis models
Favorite
12:30 – 14:30
CET
(44) M2-Macrophage Extracellular Vesicles Facilitate Metastasis in Colorectal Cancer Cells by Upregulating a Proto-Oncogene FAM83A
Favorite
12:30 – 14:30
CET
(45) Extracellular vesicles from highly invasive melanoma subpopulations increase the invasive capacity of less invasive melanoma cells through mir-1246-mediated inhibition of CCNG2
Favorite
12:30 – 14:30
CET
(46) Extracellular vesicle-mediated crosstalk in 2D & 3D cancer microenvironment
Favorite
12:30 – 14:30
CET
(48) Tumoral hypoxic extracellular vesicles protect the triple-negative breast tumor microenvironment from macrophage phagoptosis
Favorite
12:30 – 14:30
CET
(49) Investigating lipid raft composition of extracellular vesicles secreted by triple-negative breast cancer and non-cancerous breast cells to develop an optimal cancer-targeting EV-mimetic formulation
Favorite
12:30 – 14:30
CET
(50) Cerebellar mitovesicle secretion is altered in spinocerebellar ataxia and regulated by the activity of the potassium channel Kv3
Favorite
12:30 – 14:30
CET
(51) Exploring the role of mesenchymal stem cell-derived extracellular vesicles in Alzheimer's disease: the impact of MSC preconditioning on targeted therapeutic efficacy
Favorite
12:30 – 14:30
CET
(53) A Novel extracellular vesicle-based approach for targeted ferroptosis to overcome chemoresistance in lung cancer
Favorite
12:30 – 14:30
CET
(54) Exosomal miR-10b-3p deriving from umbilical mesenchymal stem cells alleviate ischemia-reperfusion acute kidney injury by targeting and inhibiting renal tubular CH25H/25OHC
Favorite
12:30 – 14:30
CET
(55) Decoding the miRNA cargo of bone marrow-derived MSC-EVs and their mRNA targets: A transcriptomic approach to improve the management of corneal disorders
Favorite
12:30 – 14:30
CET
(56) Cargo delivery via tumor-derived extracellular vesicle enhances T cell stemness via enhancing cGAS-STING pathway
Favorite
12:30 – 14:30
CET
(57) Harnessing the power of dental pulp stem cells: exosomes as a promising therapy for keloid inhibition
Favorite
12:30 – 14:30
CET
(58) Mesenchymal stem cells-derived extracellular vesicles-delivered let-7a-5p and miR-16-5p ameliorate inflammation and glycolysis by inhibition of TLR4/NF-κB pathway in sepsis-acute kidney injury
Favorite
12:30 – 14:30
CET
(59) Over six years and 2500 procedures using single-source MSC exosomes in patients
Favorite
12:30 – 14:30
CET
(60) Detection of integrin α6β4 on CD9-enriched extracellular vesicles derived from tumor cells informs the treatment with CY001 to optimize precision medicine strategies for pancreatic ductal adenocarcinoma
Favorite
12:30 – 14:30
CET
(61) Epimedium brevicornu Maxim-derived extracellular vesicle-like particles reverse postmenopausal osteoporosis by promoting angiogenesis in human umbilical vein endothelial cells
Favorite
12:30 – 14:30
CET
(62) Tissue-derived EV transcriptomic profile reveals prostate cancer evolutional response and molecular signature following neoadjuvant therapy
Favorite
12:30 – 14:30
CET
(63) Extracellular vesicle characteristics are indicative of extracorporeal photopheresis response for graft versus host disease
Favorite
12:30 – 14:30
CET
(64) The potential mechanisms of pulmonary fibrosis management via mesenchymal stromal cells extracellular vesicles include alveolar macrophages polarization regulation
Favorite
12:30 – 14:30
CET
(65) Key metabolites of serum extracellular vesicles facilitate precise identification of prostate cancer patients with PI-RADS ≥ 3 lesions
Favorite
12:30 – 14:30
CET
(66) Extracellular vesicle associated cytokines as novel biomarkers in ER-positive Breast Cancer
Favorite
12:30 – 14:30
CET
(67) ELISA-based assay using urinary extracellular vesicles for diagnosis of chronic kidney disease
Favorite
12:30 – 14:30
CET
(68) Cellulose Nanofiber Sheet-Based Extracellular Vesicle miRNA Profiles as Biomarkers for Ovarian Cancer
Favorite
12:30 – 14:30
CET
(69) Extracellular vesicles characterization in human fecal samples and quality control
Favorite
12:30 – 14:30
CET
(70) Extracellular vesicles (EVs) as biomarker for chronic graft vs. host disease, and the therapeutic potential of placental cell-derived EVs
Favorite
12:30 – 14:30
CET
(71) Hyaluronan (HA)-coated extracellular vesicles in (neuro)inflammation and improvement of Long COVID symptoms by pharmaceutical HA suppression
Favorite
12:30 – 14:30
CET
(72) Preoperative Identification of Diagnostic and Functional EV Biomarkers PDGFB and TIMP3 in Head and Neck Cancer Plasma Using High Resolution Proteomics via LC-MS/MS
Favorite
12:30 – 14:30
CET
(73) Novel peptide primes mesenchymal stem cells-derived extracellular vesicles suppress osteoarthritis by the induction of SOX9 and Collagen type II
Favorite
12:30 – 14:30
CET
(74) EPS-urine derived extracellular vesicles: multi-omics profiling for prostate cancer risk stratification
Favorite
12:30 – 14:30
CET
(75) DNA associated with large extracellular vesicles outperforms circulating cell-free DNA for the detection of oncogenic mutations in liquid biopsies of non-small cell lung cancer patients
Favorite
12:30 – 14:30
CET
(76) The Assessment of Cardiovascular Risk by Extracellular Vesicle profiling: the importance of Age- and Sex- related variations
Favorite
12:30 – 14:30
CET
(77) Extracellular vesicles’ lipidome as a source of biomarkers for cancer detection and monitoring
Favorite
12:30 – 14:30
CET
(78) Diagnostic Potential of Pleural Fluid-Derived Extracellular Vesicles in Differentiating Pleural-Associated Diseases Using Machine Learning
Favorite
12:30 – 14:30
CET
(79) Mitochondrial content of large and small extracellular vesicles in aging and autoimmunity
Favorite
12:30 – 14:30
CET
(80) Protein profile in Urinary Extracellular Vesicles is a marker of malignancy and correlates with muscle invasiveness in Urinary Bladder Cancer
Favorite
12:30 – 14:30
CET
(81) Serum extracellular vesicles enriched for neuronal origin provide a schizophrenia associated miRNA signature of treatment resistance and cognitive impairment
Favorite
12:30 – 14:30
CET
(82) Exploring the Role of CD9-Positive Extracellular Vesicles in Major Depressive Disorder: Associations with Symptom Severity and Potential Physiological Implications
Favorite
12:30 – 14:30
CET
(83) EVs as circulating biomarker of in radio-induced cardiotoxicity in breast cancer (BC)
Favorite
12:30 – 14:30
CET
(84) Characterisation of extracellular vesicles in patients with hypertrophic cardiomyopathy
Favorite
12:30 – 14:30
CET
(85) Symptomatic Menopausal Women Not Responding to Hormone Replacement Therapy May Increase their Bone and Cardiovascular Risk: A Pilot Study Investigating Extracellular Vesicle Protein Cargo
Favorite
12:30 – 14:30
CET
(86) Proinflammatory Phenotype of Saliva Extracellular Vesicles
Favorite
12:30 – 14:30
CET
(87) Proteomic profiling of extracellular vesicles reveals novel biomarkers for screening high risk patients for biliary tract cancer among those with benign biliary tract diseases
Favorite
12:30 – 14:30
CET
(88) Proteome analysis of plasma-isolated extracellular vesicles to understand signaling and treatment response in immune checkpoint inhibitor treated metastatic non-small cell lung cancer patients
Favorite
12:30 – 14:30
CET
(89) Impact of Obstructive Sleep Apnea-Derived Extracellular Vesicles on Cellular Aging
Favorite
12:30 – 14:30
CET
(90) Plasma EV protein profiling by proteomics identifies potential biomarkers for clinical phenotypes in systemic sclerosis
Favorite
12:30 – 14:30
CET
(91) Discovery of brain cell-type-specific extracellular vesicle protein biomarkers for ischemic stroke using integrated omics and bayesian data analysis
Favorite
12:30 – 14:30
CET
(92) Extracellular vesicles as a potential source of biomarkers in endometriosis and ovarian cancer
Favorite
12:30 – 14:30
CET
(94) ‘‘Exploring potential biomarkers in malaria patient biofluids derived extracellular vesicles’’
Favorite
12:30 – 14:30
CET
(95) Plasma extracellular vesicles biomarkers linked to lower muscle mass, function, and physical performance in sarcopenia
Favorite
12:30 – 14:30
CET
(96) The role of bacterial extracellular vesicles as biomarker for prognosis in colorectal cancer
Favorite
12:30 – 14:30
CET
(97) Skeletal muscle-derived extracellular vesicles as source of biomarkers for facioscapulohumeral muscular dystrophy
Favorite
12:30 – 14:30
CET
(98) Investigating small extracellular vesicle microRNA as stable biomarkers for prenatal alcohol exposure
Favorite
12:30 – 14:30
CET
(99) Exploring EV pathology and treatment efficacy in ALS through lymphoblastoid cell lines
Favorite
12:30 – 14:30
CET
(100) Small extracellular vesicle-derived miRNAs detected in organ preservation solution after cold ischemia storage impair endothelial homeostasis and influence early allograft function after liver transplantation
Favorite
12:30 – 14:30
CET
(101) Role of Extracellular Vesicles in Mediating Circadian Disruption Effects on Colorectal Cancer Progression and Drug Resistance
Favorite
12:30 – 14:30
CET
(102) Isolation, Molecular Characterization, and Anti-inflammatory Potential of Extracellular Vesicles from Edwardsiella piscicida
Favorite
12:30 – 14:30
CET
(103) Development of tumor-specific EV-miRNA signatures to improve lung cancer early detection (EV-miR-Test)
Favorite
12:30 – 14:30
CET
(104) Decoding EV-miRNA-regulated neurodegenerative pathways in the aftermath of COVID-19
Favorite
12:30 – 14:30
CET
(105) Chemotherapy resistance in triple-negative breast cancer mediated by extracellular vesicles and vesicular RNA
Favorite
12:30 – 14:30
CET
(106) Exosomal and cfDNA in diagnosis and treatment of colorectal cancer
Favorite
12:30 – 14:30
CET
(107) Bacille Calmette-Guérin immunotherapy failure in bladder cancer patients: unlocking the world of miRNAs derived from urinary extracellular vesicles
Favorite
12:30 – 14:30
CET
(108) Circulating extracellular vesicles participate in platelet aggregation in patients with burn injury complicated by sepsis
Favorite
12:30 – 14:30
CET
(109) A multiomic investigation of human milk extracellular vesicles in perinatal HIV and antiretroviral therapy exposure
Favorite
12:30 – 14:30
CET
(110) Proteomic Profiling of Extracellular Vesicles from iPSC-Derived Brain Organoids in Alzheimer’s Disease
Favorite
12:30 – 14:30
CET
(111) Diagnostic potential of urinary EVs of tubular and glomerular origin in early diabetic nephropathy
Favorite
12:30 – 14:30
CET
(112) MicroRNAs in extracellular vesicles, liver, and plasma in chronic HCV infected individuals
Favorite
12:30 – 14:30
CET
(113) Extracellular vesicles as carriers of pathogenic α-synuclein in neurodegenerative diseases
Favorite
12:30 – 14:30
CET
(114) High blood concentration of CD45-EPCAM+ extracellular vesicles is associated with metastatic disease and poor survival in patients with pancreatic cancer
Favorite
12:30 – 14:30
CET
(115) Hairy cell leukemia as a paradigm of rare tumors: multiparametric profiling of plasma small and large extracellular vesicles unveal a biology-related and disease-specific signature
Favorite
12:30 – 14:30
CET
(117) Proteomic and lipidomic profiling of plasma extracellular vesicles in multiple sclerosis
Favorite
12:30 – 14:30
CET
(118) Clinical development of multi-omic protein and miRNA biomarker signatures for multiple myeloma EV liquid biopsy: identification, validation, and AI-assisted analysis
Favorite
12:30 – 14:30
CET
(119) Platelet-derived exosomes may function as a prospective diagnostic marker and therapeutic target in sepsis
Favorite
12:30 – 14:30
CET
(120) This abstract is about FCN3 and ITIH2 expression in the extracellular vesicles from plasma of breast cancer women are novel candidates to be used as predictive biomarkers.
Favorite
12:30 – 14:30
CET
(121) Glycan and protein-sensing nanotech for extracellular vesicle-based lung cancer screening and immunotherapy response prediction
Favorite
12:30 – 14:30
CET
(122) Circulating extracellular vesicles with immunomodulatory properties and biomarker potential in obesity-related complications.
Favorite
12:30 – 14:30
CET
(123) Unveiling the Role of Extracellular Vesicle miRNAs in NAFLD Pathogenesis and Therapy
Favorite
12:30 – 14:30
CET
(124) Mirnomic analysis of urine extracellular vesicles from type 2 diabetic patients under SGLT2 inhibitors treatment: identification of biomarkers for therapeutic response
Favorite
12:30 – 14:30
CET
(127) Immuno-qPCR: a simple and powerful tool for high-throughput EV surface protein profiling across diverse biofluids
Favorite
12:30 – 14:30
CET
(128) Alteration of the circulating EV miR profiles in hypertensive conditions
Favorite
12:30 – 14:30
CET
(130) Delivery of hif1a via extracellular vesicles with collagen binding activity for enhanced wound healing
Favorite
12:30 – 14:30
CET
(131) Mesenchymal stem cell apoptotic bodies: warriors against inflammation
Favorite
12:30 – 14:30
CET
(132) Biomimetic nanostructural materials composed of placental amniotic membrane-derived extracellular vesicles for self-healing and anti-adhesion during cesarean section
Favorite
12:30 – 14:30
CET
(133) Arg1 Protein Delivered by Exosome Restores Arginase 1 Expression, Reduced Arginine Concentration in Plasma and Elongates Arg1-/- Mice Survival
Favorite
12:30 – 14:30
CET
(134) “Delivering immunomodulatory cytokine licensed human bone marrow derived MSC-EVs to the ocular surface using an innovative fluid gel system”
Favorite
12:30 – 14:30
CET
(135) Encapsulation within bacterial vesicles increases the effectiveness of antibiotics against Gram-negative bacteria
Favorite
12:30 – 14:30
CET
(137) Delivery of HIF1α via Extracellular Vesicles Induces Macrophage Reprogramming into a Resolutive Phenotype in Sepsis-Induced Liver Damage
Favorite
12:30 – 14:30
CET
(138) Neuroprotective role of Colostrum extracellular vesicles In Parkinson’s Disease
Favorite
12:30 – 14:30
CET
(139) Müller Glia-Secreted Small Extracellular Vesicles as Potential Therapy of Early-Stage Diabetic Retinopathy
Favorite
12:30 – 14:30
CET
(140) 3D bioprinting of osteoblast-derived small extracellular vesicle scaffolds for enhanced osteogenic differentiation and bone regeneration
Favorite
12:30 – 14:30
CET
(141) Targeting extracellular vesicle secretion in combination with Venetoclax synergistically induces apoptosis in FLT3-ITD+ AML
Favorite
12:30 – 14:30
CET
(142) Extracellular vesicle therapy with HIF-1α for hindlimb ischemia
Favorite
12:30 – 14:30
CET
(143) VivaZome proprietary human cell-derived extracellular vesicles improve functional outcomes after moderate traumatic brain injury in a preclinical model
Favorite
12:30 – 14:30
CET
(144) Magnetic Ion Channel Activation (MICA) enabled Extracellular Vesicles (EVs) synthesis: a new therapeutic pathway to promote osteogenic differentiation
Favorite
12:30 – 14:30
CET
(147) First-in-human application of human umbilical cord-derived extracellular vesicles for neuroprotection in spina bifida surgery
Favorite
12:30 – 14:30
CET
(148) Exosome platform: ExoPTEN as a breakthrough therapy for acute spinal cord injury, nerve regeneration, and beyond
Favorite
12:30 – 14:30
CET
(149) Therapeutic Potential of Umbilical Cord Mesenchymal Stromal Cell-Derived Extracellular Vesicles on Atopic Dermatitis: Animal Study
Favorite
12:30 – 14:30
CET
(150) Mesenchymal-derived bone cells regulate osteoclastogenesis via an extracellular vesicle-mediated mechanism
Favorite
12:30 – 14:30
CET
(152) Engineered extracellular vesicles with anti-senescence mRNA attenuate cellular senescence-associated secretory phenotype in human primary cells
Favorite
12:30 – 14:30
CET
(153) WNT3A-loaded bi-layered microwell scaffolds enhance stemness and extracellular vesicle production in salivary gland stem cells for radiation-induced dysfunction recovery via YWHAZ-PI3K-AKT pathway
Favorite
12:30 – 14:30
CET
(154) Extracellular vesicles as immunomodulatory tools: From mechanisms to therapies for inflammation and regeneration
Favorite
12:30 – 14:30
CET
(155) Donor Cell Age and Type Influence Extracellular Vesicles Therapeutic Potential for Osteoarthritis Treatment
Favorite
12:30 – 14:30
CET
(156) Non-canonical supramolecular protein assembly within extracellular vesicles
Favorite
12:30 – 14:30
CET
(157) Oral delivery of MSC-EVs as a novel approach to treat inflammatory bowel disease
Favorite
12:30 – 14:30
CET
(158) EVs from reprogrammed WNT enriched human bone marrow derived MSCs can mitigate intestinal injury
Favorite
12:30 – 14:30
CET
(159) Adipose stem cell-derived nanovesicles attenuate myocardial ischemia-reperfusion injury via miR-24-3p
Favorite
12:30 – 14:30
CET
(160) Human macrophage derived EVs for tissue repair: The role of phenotype and how this can be modulated via metabolic reprogramming
Favorite
12:30 – 14:30
CET
(161) GMP-grade human mesenchymal stromal cell-derived extracellular vesicles promote anti-inflammatory and pro-regenerative effects in a murine model of inflammatory bowel disease
Favorite
12:30 – 14:30
CET
(162) Telomerized MSCs of various tissues and donors: designer cell factories for standardizable and scalable production of clinical-grade EVs
Favorite
12:30 – 14:30
CET
(163) Targeted malignant wound healing with miRNA-enhanced MSC-derived EVs in a sustained-release atelocollagen hydrogel
Favorite
12:30 – 14:30
CET
(164) Treatment of lupus nephritis using CD38 targeting peptide-modified extracellular vesicles derived from mesenchymal stem cells
Favorite
12:30 – 14:30
CET
(165) Evaluation of apple-derived vesicles for the treatment of inflammatory bowel disease
Favorite
12:30 – 14:30
CET
(166) Bioengineering matrix vesicles as a nanotherapeutic approach to endochondral bone regeneration
Favorite
12:30 – 14:30
CET
(167) Umbilical cord mesenchymal stem cell-derived small extracellular vesicles as a cocktail therapy to ameliorate sepsis-induced acute kidney injury
Favorite
12:30 – 14:30
CET
(168) High-yield production of EVs from mesenchymal stem cells using hollow fiber bioreactor
Favorite
12:30 – 14:30
CET
(169) Polydopamine-Modified Turmeric-Derived Nanovesicles Biomimetic Hydrogel System for Effective Management of Diabetic Wound Infections
Favorite
12:30 – 14:30
CET
(170) Novel Biological Therapies for Pancreatic Ductal Adenocarcinoma
Favorite
12:30 – 14:30
CET
(172) Clinical-grade extracellular vesicles isolated from telomerized mesenchymal stromal cells maintain biological activity over time
Favorite
12:30 – 14:30
CET
(173) Plant-derived nanovesicles screening and compatibility mechanism based on glioma organoid chip
Favorite
12:30 – 14:30
CET
(174) Lyophilized Small Extracellular Vesicles (sEV) from glycolytically activated mesenchymal stem/stromal cells promote chondroprotection in vitro and cartilage regeneration in vivo
Favorite
12:30 – 14:30
CET
(175) Unlocking the potential of exosomes generated from induced pluripotent stem cell-derived skin organoids for wound healing
Favorite
12:30 – 14:30
CET
(176) Targeted extracellular vesicles and doxorubicin formulation potential for triple negative breast cancer
Favorite
12:30 – 14:30
CET
(177) Innovative AIE-engineered extracellular vesicles to remodel microenvironment for infected wound healing
Favorite
12:30 – 14:30
CET
(178) The Neuroprotective Effect of a Complex Multi-strain Probiotic Secreted Formulation in Alzheimer's Disease
Favorite
12:30 – 14:30
CET
(179) Plant-derived vesicles as potential therapy for neuroendocrine prostate cancer
Favorite
12:30 – 14:30
CET
(180) microRNA boosted EVs for cardiovascular disease
Favorite
12:30 – 14:30
CET
(181) Hypoxia-driven CAIX: a potential target to reduce extracellular vesicles release in cancer
Favorite
12:30 – 14:30
CET
(183) Advantages and disadvantages of siRNA-carrier using autologous serum-derived small EVs compared with other types of nanoparticles
Favorite
12:30 – 14:30
CET
(184) Specific lung tumor targeting way by lung cancer small extracellular vesicles (sEVs) based antibody
Favorite
12:30 – 14:30
CET
(185) Hydrogel-encapsulated exosome vaccine as a novel immunotherapeutic approach and its role in enhancing immunotherapy for prostate cancer
Favorite
12:30 – 14:30
CET
(187) SMAC mimetics and type I interferon induce tumor cell death and boost immune response through small extracellular vesicles
Favorite
12:30 – 14:30
CET
(188) Engineered bacterial outer membrane vesicles enhance immunotherapy efficacy by remodeling the immune microenvironment through bidirectional ferroptosis induction
Favorite
12:30 – 14:30
CET
(189) Engineering bispecific extracellular vesicles for cancer immunotherapy
Favorite
12:30 – 14:30
CET
(190) Multi-Omic Profiling of Circulating Extracellular Vesicles to Identify Response Signatures and Resistance Mechanisms in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Favorite
12:30 – 14:30
CET
(191) Bdellovibrio bacteriovorus-derived extracellular vesicles enhance the therapeutic effect of immune checkpoint inhibitor
Favorite
12:30 – 14:30
CET
(192) CAR-T cell derived extracellular vesicles express high levels of CAR and carry pro-apoptotic molecules, mimicking CAR-T cell anti-tumor activity
Favorite
12:30 – 14:30
CET
(193) Killer EVs: Enhancing ex vivo production of cytotoxic extracellular vesicles from cord blood natural killer cells for effective cancer immunotherapy
Favorite
12:30 – 14:30
CET
(194) Anti-cancer Effect of Extracellular Vesicles-derived from IL-21 Activated NK-92 Cells Against Breast Cancer Cell Lines
Favorite
12:30 – 14:30
CET
(195) Anticancer activity of extracellular vesicles from natural killer cells cultured under different conditions against human oral squamous cell carcinoma
Favorite
12:30 – 14:30
CET
(196) Gut pathobiont–derived Outer Membrane Vesicles drive liver inflammation and fibrosis in PSC-IBD
Favorite
12:30 – 14:30
CET
(197) Dissect human islet-derived extracellular vesicle heterogeneity for type 1 diabetes early diagnosis and pathogenesis
Favorite
12:30 – 14:30
CET
(198) Skeletal muscle-derived extracellular vesicles and their impact on glucose regulation in type 2 diabetes
Favorite
12:30 – 14:30
CET
(199) Fourier-Transform InfraRed (FT-IR) spectroscopy to show alterations in molecular composition of EVs subpopulations derived from beta-pancreatic cells cultured in different D-glucose condition.
Favorite
12:30 – 14:30
CET
(200) Three-dimensional in vitro model of liver fibrosis to test the effects of extracellular vesicles released by mesenchymal stromal cells
Favorite
12:30 – 14:30
CET
(203) An Adiponectin Receptor Agonist Protects Against Myocardial Ischemia-Reperfusion Injury by Promoting Rab8a-mediated Extracellular Vesicle Release
Favorite
12:30 – 14:30
CET
(204) Bioengineered Adiponectin EVs prevent obesity-related metabolic complications by improving insulin sensitivity
Favorite
12:30 – 14:30
CET
(205) Injected Extracellular Vesicles hitchhike on Erythrocytes and Platelets from circulation towards organ clearance
Favorite
12:30 – 14:30
CET
(206) Acute Toxicity Testing of Extracellular Vesicles from Umbilical Cord Mesenchymal Stem Cells: Assessment in Lungs and Spleen as Target Organs
Favorite
12:30 – 14:30
CET
(207) Regulatory considerations on characterization and quality control of therapeutic EV products
Favorite
12:30 – 14:30
CET
(208) Milk Extracellular Vesicles for Enhanced Delivery of Zeaxanthin: Exploring Bioavailability and Aryl Hydrocarbon Receptor Activation in Immunomodulation
Favorite
12:30 – 14:30
CET
(209) Agri-food residues as source of bioactive Nanovesicles: a new perspective to valorize agricultural by-products
Favorite
12:30 – 14:30
CET
(211) Exploring the hemostatic Role of platelet-derived EVs: Comparative analysis of platelet lysates vs. activation-induced EV release
Favorite
12:30 – 14:30
CET
(212) Pioneering the Development of Novel Human Platelet-Derived Exosomes for Improved Therapeutic Applications in Biomedical Field
Favorite
12:30 – 14:30
CET
(213) Cloudberry plant derived nanovesicles for oral drug delivery system: Stability in gastrointestinal conditions and biodistribution in young and elder mice
Favorite
12:30 – 14:30
CET
(214) Milk-derived extracellular vesicles as drug delivery vehicle for myricetin
Favorite
12:30 – 14:30
CET
(215) Anticancer activity of fingerroot exosome-like nanovesicles in atypical teratoid/rhabdoid tumor (AT/RT)
Favorite
12:30 – 14:30
CET
(216) A novel method for the isolation of plant-derived exosome-like nanovesicles from fruit juices by polyethylene glycol-mediated preferential precipitation
Favorite
12:30 – 14:30
CET
(217) Microcarrier based platform process for adherend cells to produce extracellular vesicles
Favorite
12:30 – 14:30
CET
(218) Exosomes Engineered for Reprogramming Tumor-Associated Macrophages and Blocking PD-L1 Immune Checkpoint
Favorite
12:30 – 14:30
CET
(219) Comprehensive identification and characterization of the biological properties of HEK293F cell-derived small extracellular vesicles as promising drug delivery systems
Favorite
12:30 – 14:30
CET
(220) Effect of Benzo[a]Pyrene on the production by endothelial HMEC-1 cells of large extracellular vesicles containing mitochondria
Favorite
12:30 – 14:30
CET
(221) The analysis of eicosanoids contained in macrophage-derived extracellular vesicles
Favorite
12:30 – 14:30
CET
(222) Why are EVs special? Demonstrating the carrier effects using designer EVs
Favorite
12:30 – 14:30
CET
(224) Modulation of environmental and microbiome interactions by bacterial extracellular vesicles
Favorite
12:30 – 14:30
CET
(225) Investigations into EV production from nitrogen-fixing bacteria found naturally in soil
Favorite
12:30 – 14:30
CET
(226) The adaptor protein CD2AP controls the biogenesis of Syntenin exosomes
Favorite
12:30 – 14:30
CET
(227) A phosphoinositide switch mediates exocyst recruitment to multivesicular endosomes for exosome secretion
Favorite
12:30 – 14:30
CET
(228) Full-length tRNAs lacking a functional CCA tail are selectively sorted into the lumen of extracellular vesicles
Favorite
12:30 – 14:30
CET
(229) Secretion of Rab31 Play a Role Exosome Biogenesis Under Hypoxic Condition in Adipogenic Mesenchymal Stem Cells
Favorite
12:30 – 14:30
CET
(230) PCBP2-dependent secretion of miRNAs via extracellular vesicles contributes to the EGFR-driven angiogenesis
Favorite
12:30 – 14:30
CET
(231) Caveolin-1 overexpression induces extracellular vesicle release and protein cargo impairment in an in vitro model of rhabdomyosarcoma
Favorite
12:30 – 14:30
CET
(233) Distinct signature proteins control the sEV biogenesis in cancer cells and stem cells
Favorite
12:30 – 14:30
CET
(234) Evaluation of engineering tetraspanin knockout cells with tetraspanin fusion constructs
Favorite
12:30 – 14:30
CET
(235) Role of syntenin in autophagy-dependent secretion
Favorite
12:30 – 14:30
CET
(236) Hypoxia regulates small extracellular vesicle biogenesis and cargo sorting through HIF-1α/HRS signaling pathway in head and neck squamous cell carcinoma
Favorite
12:30 – 14:30
CET
(237) Aging-induced extracellular vesicles from lung cells carry a specific SASP
Favorite
12:30 – 14:30
CET
(238) Hypoxia promotes re-localization of Rab17 into endolysosomal compartments, inducing the release of pro-angiogenic small extracellular vesicles in A549 cancer cells
Favorite
12:30 – 14:30
CET
(239) A comparative study of inhibitors targeting extracellular vesicle biogenesis
Favorite
12:30 – 14:30
CET
(240) Regulatory mechanisms of sEV secretion via UBXN family proteins
Favorite
12:30 – 14:30
CET
(241) ECM rigidity boosts the biogenesis of extracellular vesicles in breast cancer cells via TSG101-HSP90 axis
Favorite
12:30 – 14:30
CET
(242) Development of an optogenetic tool to modulate exosome secretion through inducible membrane contact sites
Favorite
12:30 – 14:30
CET
(243) Monocyte differentiation and function are immunoregulated by exosomes derived from the synovial fluid of osteoarthritis patients
Favorite
12:30 – 14:30
CET
(244) Cancer-derived EVs elicit immune suppressive effects in healthy immune cells
Favorite
12:30 – 14:30
CET
(245) Exosome Release as a Key Modulator of Cell Survival and Death in TSC-Null Cells Under Glucose Deprivation
Favorite
12:30 – 14:30
CET
(246) Extracellular vesicles from L. paracasei improve neuroinflammation, GABA neurotransmission and motor incoordination in hyperammonemic rats
Favorite
12:30 – 14:30
CET
(247) Small extracellular vesicles from Obese-Adipose tissue promote dysfunction in distal organ
Favorite
12:30 – 14:30
CET
(248) Probiotic extracellular vesicles: isolation, characterization and evaluation of their immunomodulatory properties
Favorite
12:30 – 14:30
CET
(250) Menstrual blood-derived mesenchymal stromal cell extracellular vesicles stimulate stem cell and chondrocyte functions and diminish osteoarthritic cartilage degradation in vitro
Favorite
12:30 – 14:30
CET
(251) Polygonum cuspidatum derived nanoparticle-mediated miR-5054 delivery reverses oxidative stress in HUVECs by Keap1-Nrf2 antioxidant pathway
Favorite
12:30 – 14:30
CET
(252) Genome-wide CRISPR/Cas9 screening identifies the COMMANDER recycling complex as a key player in EV uptake
Favorite
12:30 – 14:30
CET
(253) Extracellular vesicle transport across the vascular endothelium
Favorite
12:30 – 14:30
CET
(254) Tumor Extracellular Vesicles Educated Platelet Ribosomal Protein-mRNA Degradation
Favorite
12:30 – 14:30
CET
(255) The Impact of Nucleus Pulposus Cell Exosomes under Cyclic Mechanical Tension on Nucleus Pulposus Cells
Favorite
12:30 – 14:30
CET
(256) Enhancing cellular uptake of extracellular vesicles via genomic glycoengineering
Favorite
12:30 – 14:30
CET
(257) Identifying molecular drivers of extracellular vesicle-mediated RNA transfer
Favorite
12:30 – 14:30
CET
(258) Cross-species communication via fungal extracellular vesicles
Favorite
12:30 – 14:30
CET
(259) EV mediated cross-kingdom RNA trafficking between plants and fungal pathogens
Favorite
12:30 – 14:30
CET
(260) EVs from PDAC cells harboring mutant p53 can drive tumor microenvironment remodeling and fibroblast activation
Favorite
12:30 – 14:30
CET
(261) Investigating the uptake dynamics of hyaluronic acid-decorated extracellular vesicles using high-content screening
Favorite
12:30 – 14:30
CET
(262) Impact of Irradiation on Extracellular Vesicle Release in Medulloblastoma and Its Effects on Neural Progenitor Cells
Favorite
12:30 – 14:30
CET
(263) Visualizing the EV-mediated AMR transfer process of the ESBL Plasmid derived from Escherichia coli O104:H4
Favorite
12:30 – 14:30
CET
(264) Host Immune Cell Membrane Deformability Governs the Uptake Route of Malaria-Derived Extracellular Vesicles
Favorite
12:30 – 14:30
CET
(266) Mesoangioblast extracellular vesicles modulate macrophage behavior
Favorite
12:30 – 14:30
CET
(268) Decoding the versatile landscape of Bacillus cereus extracellular vesicles: A multi-OMICS approach
Favorite
12:30 – 14:30
CET
(269) miRNA content in subpopulations of NK cell-derived extracellular vesicles connects to different functional activity
Favorite
12:30 – 14:30
CET
(270) Bone-Derived Matrix Vesicles as a Multi-Targeted Therapeutic Strategy for Bone Regeneration
Favorite
12:30 – 14:30
CET
(271) Deciphering the Heterogeneity Landscape of Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles for Precise Selection in Translational Medicine
Favorite
12:30 – 14:30
CET
(272) Analysis Extracellular vesicles in CLL subtypes using direct stochastic optical reconstruction microscopy.
Favorite
12:30 – 14:30
CET
(273) Unbiased analysis of single extracellular vesicles by nano-flow cytometry reliably unravels their population changes in different sources and upon different stimuli
Favorite
12:30 – 14:30
CET
(276) Characterization and comparative analysis of extracellular vesicles (EV) from B cell lymphoma cultures and patient serum: Highlighting methodological variations across EV isolates
Favorite
12:30 – 14:30
CET
(277) Common properties of extracellular nanoparticles from various sources: utilizing chromatography for a comprehensive characterization of complex samples
Favorite
12:30 – 14:30
CET
(278) EV preparations from telomerized Mesenchymal Stromal Cell lines elicit robust performance in therapeutically relevant models
Favorite
12:30 – 14:30
CET
(279) Extracellular vesicles define discrete nano-based niches within the human haematopoietic system
Favorite
12:30 – 14:30
CET
(280) Context-dependent roles of extracellular vesicle subtypes in tumor angiogenic signaling
Favorite
12:30 – 14:30
CET
(281) Know Your Vesicles: How Cell Source Shapes Extracellular Vesicle Attributes
Favorite
12:30 – 14:30
CET
(282) Probiotic extracellular vesicles as potential immune mediators
Favorite
12:30 – 14:30
CET
(283) Culprit site EV protein signatures uncover molecular details of plaque rupture in acute myocardial infarction
Favorite
12:30 – 14:30
CET
(284) Role of SERINC proteins on EV lipid content
Favorite
12:30 – 14:30
CET
(285) Exosomes are necessary and sufficient for fibronectin assembly
Favorite
12:30 – 14:30
CET
(286) Suppression of Senescence-Associated Inflammation by Secretome and EVs Derived from hTSCs
Favorite
12:30 – 14:30
CET
(287) Hypoxic stress mediates cardiac extracellular vesicle release and transcriptional changes in bystander cells
Favorite
12:30 – 14:30
CET
(288) Drugs impairing the autophagic flux point out a role for autophagic machinery in the release of extracellular vesicles
Favorite
12:30 – 14:30
CET
(289) Human amniotic fluid-derived EVs increase regenerative ability of early-senescent human dermal fibroblasts
Favorite
12:30 – 14:30
CET
(290) Caspase inhibitors attenuate extracellular vesicle-mediated cell death in microglia and astrocytes in people living with HIV
Favorite
12:30 – 14:30
CET
(291) Phenotypic and functional changes of iron-laden microglia: involvement of EVs in paracrine senescence.
Favorite
12:30 – 14:30
CET
(292) This abstract is about the Assessment of large extracellular vesicle protein cargo following TGF-beta induced apoptosis of mammary epithelial cells
Favorite
12:30 – 14:30
CET
(293) Overcome senescence through the reduction in sEV biogenesis
Favorite
12:30 – 14:30
CET
(294) Differential uptake and trafficking of extracellular vesicles affected by oncogenic RAS and RAF
Favorite
12:30 – 14:30
CET
(296) Artificial intelligence-supported platform for quantitative analysis of the intercellular communication network in multicellular tumor spheroids
Favorite
12:30 – 14:30
CET
(297) Pharmacokinetic Analysis on the Efficacy of Intravenously Administered Exosomes
Favorite
12:30 – 14:30
CET
(298) Potential test of peripheral blood and umbilical cord blood-derived dendritic cells with endogenic and synthetic specific antigen induction on T cell activation in nasopharyngeal carcinoma patients
Favorite
12:30 – 14:30
CET
(299) Development of a Hybrid Extracellular Vesicles/Liposome System for Enhanced Skin Anti-Inflammation
Favorite
12:30 – 14:30
CET
(300) Hoffa-MSC-derived EVs produced in 3D vertical wheel bioreactor culture more potently regenerate primary osteoarthritic chondrocytes than EVs from 2D culture
Favorite
12:30 – 14:30
CET
(301) Single-Cell Analysis of L-Myc Expressing Neural Stem Cells and their Extracellular Vesicles Revealed Distinct Progenitor Populations with Neurogenic Potential
Favorite
12:30 – 14:30
CET
(302) Adipose tissue-derived mesenchymal stromal cells and their extracellular vesicles are functionally deficient in patients with systemic sclerosis
Favorite
12:30 – 14:30
CET
(303) Setting a protocol to incorporate mesenchymal stromal cells extracellular vesicles in platelet-derived fibrin gel for cartilage repair
Favorite
12:30 – 14:30
CET
(305) Analytical comparison of MSC-EV quality attributes across tissue sources and production platforms
Favorite
12:30 – 14:30
CET
(306) The role of miRNA-enriched etracellular vesicles fron induced MSCs in modulating inflammation and redox balance in vitro osteoarthritis model.
Favorite
12:30 – 14:30
CET
(307) Investigation of LINE-1, ORF1 and FTO in Mesenchymal Stem Cell Derived Exosomes Supporting Oocyte Maturation in vitro
Favorite
12:30 – 14:30
CET
(308) Induced mesenchymal stromal cells for therapeutic extracellular vesicle production
Favorite
12:30 – 14:30
CET
(309) Bone marrow and placenta mesenchymal stem cell-derived extracellular vesicles increase ex vivo expansion of hematopoietic stem cells
Favorite
12:30 – 14:30
CET
(310) Identification of a specific marker panel for human mesenchymal stem cell-derived small extracellular vesicles
Favorite
12:30 – 14:30
CET
(311) Bone marrow mesenchymal stromal cell derived extracellular vesicles for bone regeneration
Favorite
12:30 – 14:30
CET
(312) Exosome produced by automation-assisted derivation mesenchymal stem cells from human induced pluripotent stem cells possess immunomodulatory potentials
Favorite
12:30 – 14:30
CET
(313) Non-coding RNA and Proteomic Profiling of iPSC-derived Extracellular Vesicles: New Frontiers in Cell-free Nanomedicine for Regenerative Therapy
Favorite
12:30 – 14:30
CET
(314) EVs as mediators of indoor air pollutants-driven inflammatory systemic effects
Favorite
12:30 – 14:30
CET
(315) Engineering extracellular vesicles protein composition for targeted angiogenesis
Favorite
12:30 – 14:30
CET
(316) Extracellular RNA analysis of neuronal cell models as surrogate non-invasive markers for differentiation assessment
Favorite
12:30 – 14:30
CET
(317) Brain pericyte-derived small extracellular vesicles as modulators of blood-brain barrier endothelial cells differentiation and functions
Favorite
12:30 – 14:30
CET
(318) Metabolic reprogramming of T cells by glioblastoma-derived extracellular vesicles induces glycolysis
Favorite
12:30 – 14:30
CET
(319) 8CLC-derived Exosomes Mediate Regulatory T-Cell Retinoic Acid Metabolism Through CRABP1 to Alleviate Psoriasis
Favorite
12:30 – 14:30
CET
(320) Proteomic profiling of plasma derived small extra cellular vesicles of pancreatic neuroendocrine tumor patients and healthy control subjects
Favorite
12:30 – 14:30
CET
(321) Neuroblastoma Extracellular Vesicles mediate Blood-Brain-Barrier permeability and carry tight junctions’ proteins cargo
Favorite
12:30 – 14:30
CET
(322) Small extracellular vesicle release by corneal epithelial cells may serve as an early indicator of corneal dysfunction in dry eye disease
Favorite
12:30 – 14:30
CET
(323) Sex-differences in specialized lipid mediators in EVs, intra-, and extra-cellular compartments of human conjunctival goblet cells during allergic conjunctivitis
Favorite
12:30 – 14:30
CET
(324) Overexpression of CD73 reduces extracellular vesicle (EV)-sequestered cyclooxygenase 2 (COX-2) levels in activated J744A1 macrophages
Favorite
12:30 – 14:30
CET
(326) Bacterial stimulation alters lipid composition of macrophage-derived extracellular vesicles: Implications for immune modulation
Favorite
12:30 – 14:30
CET
(328) Extracellular vesicles and their miRNA cargo in response to physical exercise: potential involvement in oxidative stress regulation – Insights from the HEBE Study
Favorite
12:30 – 14:30
CET
(329) Unlocking cancer secrets: how short-chain fatty acids drive extracellular vesicles production in colorectal cancer
Favorite
12:30 – 14:30
CET
(330) A short form of multidrug resistance-associated protein 1 (MRP1) in plasma sEVs is a potential indicator of pancreatic ductal adenocarcinoma
Favorite
12:30 – 14:30
CET
(331) Host factor-induced bacterial extracellular vesicles promote horizontal gene transfer in Vibrio cholerae
Favorite
12:30 – 14:30
CET
(332) Mechanism of MSC-derived EVs to cross biological barriers and target specific tumoral cell types
Favorite
12:30 – 14:30
CET
(333) Urinary exosomes as non-invasive window to glomerular and tubular cells and their communication
Favorite
12:30 – 14:30
CET
(334) Extracellular vesicles in the vitreous as local mediators in proliferative diabetic retinopathy
Favorite
12:30 – 14:30
CET
(335) The gut-retina axis: how extracellular vesicles influence diabetic retinopathy progression
Favorite
12:30 – 14:30
CET
(336) Bioinformatics-driven approach for profiling the kidney source of single urine extracellular vesicles
Favorite
12:30 – 14:30
CET
(337) Paving the Way Toward a Urine-Based Extracellular-Like Vesicle Assay for Early Diagnosis of Kidney Disease
Favorite
12:30 – 14:30
CET
(338) Influence of oral sucrosomal iron versus intravenous iron sucrose administration in dialysis patients on the interaction of monocyte subsets with platelet-derived extracellular vesicles
Favorite
12:30 – 14:30
CET
(339) The protein signature of plasma extracellular vesicle in the ischemic AKI model
Favorite
12:30 – 14:30
CET
(340) Hypertonicity affects the composition of micro-RNAs in extracellular vesicles derived from renal collecting duct cells
Favorite
12:30 – 14:30
CET
(341) The surface charge of urinary extracellular vesicles as a possible predictor of kidney disease in diabetes
Favorite
12:30 – 14:30
CET
(342) Extracellular vesicles represent a glomerular exit route for autoantigens in membranous nephropathy
Favorite
12:30 – 14:30
CET
(343) Urinary extracellular vesicles as non-invasive biomarkers for early detection of kidney transplant injury
Favorite
12:30 – 14:30
CET
(344) Shiga toxin in extracellular vesicles is more potent than toxin alone in a mouse model of kidney disease
Favorite
12:30 – 14:30
CET
(345) Understanding impact of proteinuria on uEV excretion in patients with diabetic kidney disease over the course of a day
Favorite
12:30 – 14:30
CET
(346) Mechanical stress induces phenotypic alterations in extracellular vesicles derived from renal cell carcinoma tissues
Favorite
12:30 – 14:30
CET
(347) Extracellular vesicles from adiponectin knockout mice have an altered proteome and mediate direct adverse functional metabolic effects in target cells
Favorite
12:30 – 14:30
CET
(348) Adipocyte-derived extracellular vesicles accelerate obesity-associated comorbidities
Favorite
12:30 – 14:30
CET
(349) MSTN mutant pig serum exosomes reduce fat deposition in obese mice by inducing browning of white fat
Favorite
12:30 – 14:30
CET
(350) Metabolomic Profiling of Size-Exclusion Chromatography-Isolated Plasma-derived Extracellular Vesicles from Healthy Donors
Favorite
12:30 – 14:30
CET
(351) Tumour Extracellular Vesicles and Particles (EVPs) Induce Aberrant Lipid Metabolism
Favorite
12:30 – 14:30
CET
(352) Lysosomal GBA1 Alterations Affect Extracellular Vesicle Size and Frequency in Gaucher Disease
Favorite
12:30 – 14:30
CET
(353) Study of extracellular vesicles (EVs) biology in 3D-culture hepatic models of liver disease
Favorite
12:30 – 14:30
CET
(354) Extracellular vesicles: novel biomarkers of endocrine disrupting chemical exposure in metabolic disfunction associated steatotic liver disease (MASLD)
Favorite
12:30 – 14:30
CET
(356) Effects of aerobic-strength training on glucose metabolism, cognitive functions, and proteome of circulating extracellular vesicles in patients with Parkinson’s disease
Favorite
12:30 – 14:30
CET
(357) Stimulatory effects of a subpopulation of bovine milk extracellular vesicles with collagen-binding properties in 2D and 3D models of osteogenesis
Favorite
12:30 – 14:30
CET
(358) The role of galectins in extracellular vesicle-mediated tissue communication in osteoarthritis
Favorite
12:30 – 14:30
CET
(359) Exosomes from myostatin-mutant pig serum promote C2C12 cell differentiation and skeletal muscle growth
Favorite
12:30 – 14:30
CET
(360) Exploring the effect of extracellular vesicles derived from human dental pulp stem cells in dexamethasone-induced muscle atrophy
Favorite
12:30 – 14:30
CET
(361) Plasma EV proteomics in a community-based cohort reveal novel biomarkers for sarcopenia and functional decline
Favorite
12:30 – 14:30
CET
(362) Denervated skeletal muscle-derived extracellular vesicles: insights into molecular responses to nerve injury
Favorite
12:30 – 14:30
CET
(364) Hypoxia-upregulated membrane protein ATXN2 enhances the uptake of neuronal small extracellular vesicles to ameliorate ischemic brain injury
Favorite
12:30 – 14:30
CET
(365) Altered Small Extracellular vesicles exclusively interact with small amyloid-β aggregates and accelerate fibrillation: A Risk for AD progression
Favorite
12:30 – 14:30
CET
(366) Astrocyte-enriched extracellular vesicles as mediators of synaptic endurance after stroke
Favorite
12:30 – 14:30
CET
(367) Investigating the role of exercise linked-irisin and extracellular vesicles in Alzheimer’s disease
Favorite
12:30 – 14:30
CET
(368) Visualizing proteopathic Tau seeds within Alzheimer’s disease brain-derived extracellular vesicles by single molecule localization microscopy
Favorite
12:30 – 14:30
CET
(369) Regenerative potential of mesenchymal stem cell-derived extracellular vesicles loaded with PTEN small interfering RNA for facial nerve injury
Favorite
12:30 – 14:30
CET
(370) Intercellular communication through Schwann cell-derived extracellular vesicles in peripheral neuropathy
Favorite
12:30 – 14:30
CET
(371) Microvesicles carrying EV71 virions cross the blood-brain barrier through endocytic pathway to induce brain injury
Favorite
12:30 – 14:30
CET
(372) Raman Spectroscopy analysis of alpha synuclein in salivary extracellular vesicles for the early diagnosis of Parkinson disease
Favorite
12:30 – 14:30
CET
(374) Neuron-Targeted Nanoparticle-EV Complex for Specific Brain Delivery: A Platform for Early Diagnosis and Treatment of Neurodegenerative Disease
Favorite
12:30 – 14:30
CET
(375) Tracking Adipose-Derived Stem Cell Exosomes Applied in a Mouse Crush Injury Model: Insights from Fluorescent Labeling and Spatial Transcriptomics – an Experimental Study
Favorite
12:30 – 14:30
CET
(376) Investigating the Influence of IL-17A Signaling in Astrocyte-Enriched Extracellular Vesicle Cargo and Its Impact on Neuronal Recovery Post-Stroke
Favorite
12:30 – 14:30
CET
(377) The transfer of sensory neuron derived extracellular vesicles to resident macrophages in dorsal root ganglia maintains persistent inflammatory pain
Favorite
12:30 – 14:30
CET
(380) Midbrain Organoid-Derived Extracellular Vesicles Reveal Potential Neurophysiological Changes in Chikungunya Virus Infection
Favorite
12:30 – 14:30
CET
(381) A brain-wide interneuronal network mediated by extracellular vesicle
Favorite
12:30 – 14:30
CET
(382) Contribution of human and murine blood serum exosomes in depressive-like behavior: focus on protein content
Favorite
12:30 – 14:30
CET
(383) Extracellular vesicles derived from HIV-infected microglia induce neuroinflammation and apoptosis
Favorite
12:30 – 14:30
CET
(384) Gut Microbiota-Derived Extracellular Vesicles Influence Alcohol Intake Preferences in Rats
Favorite
12:30 – 14:30
CET
(386) Exercise-induced small extracellular vesicles: exploring miRNA’s role in alleviating major depressive disorder
Favorite
12:30 – 14:30
CET
(387) Sex- and size-specific protein cargo variations in extracellular vesicles from oligodendrocyte progenitor cells in response to hyperoxic stress
Favorite
12:30 – 14:30
CET
(388) Influence of air pollution exposure on the microRNA content of neuronal extracellular vesicles in subjects affected by major depressive disorder
Favorite
12:30 – 14:30
CET
(389) KRAS/LKB1 co-mutated Non-Small Cell Lung Cancer reshapes fibroblasts toward an inflammatory-like phenotype through Extracellular Vesicles
Favorite
12:30 – 14:30
CET
(390) Pharmacological inhibition of acid sphingomyelinase activity reduces extracellular vesicle release from murine alveolar leukocytes during lipopolysaccharide-induced acute lung injury
Favorite
12:30 – 14:30
CET
(391) The role of glycan modification in altering lung uptake of HBEC-derived EVs for drug delivery
Favorite
12:30 – 14:30
CET
(392) Evaluation of extracellular vesicles as noninvasive early predictive markers for severe COVID-19
Favorite
12:30 – 14:30
CET
(393) Is EV-associated TG2 a marker of idiopathic pulmonary fibrosis in biofluids?
Favorite
12:30 – 14:30
CET
(394) Polymicrobial bEVs elicit a hyper-inflammatory response in cystic fibrosis bronchial epithelial cells
Favorite
12:30 – 14:30
CET
(395) Single-pot Extracellular Vesicle Isolation and Multi-Omics Workflow for Ovarian Cancer Biomarker Discovery.
Favorite
12:30 – 14:30
CET
(396) Protein Co-Enrichment in Extracellular Vesicles
Favorite
12:30 – 14:30
CET
(397) A knowledge graph model for integrating microRNAs in analyzing extracellular vesicles data
Favorite
12:30 – 14:30
CET
(398) The proteomic landscape of stool-derived extracellular vesicles in patients with pre-cancerous lesions and colorectal cancer
Favorite
12:30 – 14:30
CET
(399) An adaptation of the Nichenet method to study targeted communication network mediated by extracellular vesicles
Favorite
12:30 – 14:30
CET
(400) Development of a highly sensitive, reproducible and rapid blood EV proteome analysis platform for large-scale cohort samples
Favorite
12:30 – 14:30
CET
(401) High-throughput and multiplexed quantification of single EVs at single-molecule level
Favorite
12:30 – 14:30
CET
(402) Identification of robust and abundant EV reference mRNA transcripts from diverse biological sources
Favorite
12:30 – 14:30
CET
(403) Understanding MitoEVs: A Jurkat cell model of radiation-induced senescence and lysosomal dysfunction
Favorite
12:30 – 14:30
CET
(404) Detailed heterogeneity evaluation of EV preparation by anion exchange HPLC and various analytical methods
Favorite
12:30 – 14:30
CET
(405) Investigating the Interaction Network of Antimicrobial Peptides with Urine-Derived and Red Blood Cell-Derived Extracellular Vesicles
Favorite
12:30 – 14:30
CET
(406) gp130-enriched engineered small extracellular vesicles ameliorate septic acute lung injury by competitively binding IL-6
Favorite
12:30 – 14:30
CET
(407) Multi-omics Analysis of Extracellular Vesicles of Human Forebrain Spheroids in a Vertical-Wheel Bioreactor
Favorite
12:30 – 14:30
CET
(408) hnRNPA2b1 is a key regulator of BM-EV-miRNA cargo loading in the response of bone marrow to cellular stress initiated by ionizing radiation exposure
Favorite
12:30 – 14:30
CET
(409) Coenzyme Q10 delivery to muscle cells using exosome-mimetic nanovesicles
Favorite
12:30 – 14:30
CET
(410) High-dimensional single-cell profiling of EV recipients by Tellurium-based labeling of the EV proteome (TeLEV) identifies EV-driven transformation of the immune microenvironment in chronic lymphocytic leukemia
Favorite
12:30 – 14:30
CET
(411) Physiological vs. traditional EV administration: improved biodistribution and reduced toxicity with slow-release pumps
Favorite
12:30 – 14:30
CET
(412) DetectEV: a functional enzymatic assays to assess integrity and bioactivity of extracellular vesicles
Favorite
12:30 – 14:30
CET
(413) Probing extracellular vesicle interactions with lipoproteins in healthy and disease contexts
Favorite
12:30 – 14:30
CET
(414) Bead-based multiplex immunoassay to measure extracellular vesicles surface proteins in plasma and serum.
Favorite
12:30 – 14:30
CET
(415) In vitro models of blood brain barier or blood tumor barier to study transport of exosomes and plant derived vesicles
Favorite
12:30 – 14:30
CET
(416) Advancing EV research: Novel technique for EV’s surfaceome profiling.
Favorite
12:30 – 14:30
CET
(417) Therapeutic application of bioabsorbable nanofiber-based EV sheet toward location-specific targeted delivery of anti-cancer EVs
Favorite
12:30 – 14:30
CET
(418) Rapid EV surface decoration with targeting moieties based on a FITC binding single chain antibody snorkel
Favorite
12:30 – 14:30
CET
(419) Extracellular-vesicle mediated delivery of Cas9 adenine base editors by aptamer-based loading and UV-activated release
Favorite
12:30 – 14:30
CET
(420) Internalization of cell-penetrating peptides by cells and encapsulation in extracellular vesicles
Favorite
12:30 – 14:30
CET
(421) Encapsulation of prime editing components in extracellular vesicles using protein palmitoylation
Favorite
12:30 – 14:30
CET
(422) Extracellular vesicle-mediated delivery of Let-7a to combat peritoneal fibrosis
Favorite
12:30 – 14:30
CET
(423) Achieving specific efficient delivery of diverse protein therapeutics with circulating exosome-anchoring nanobody
Favorite
12:30 – 14:30
CET
(424) A Supramolecular Antibiotic Assembly that Kills E. coli by Enforcing Extensive Release of Bacterial EVs
Favorite
12:30 – 14:30
CET
(425) Bioengineered MSCs-Derived Extracellular Vesicles: A Novel Therapeutic Strategy for Targeting Liver Disease
Favorite
12:30 – 14:30
CET
(426) Ectopic Expression of CD39 Enhances Immunomodulatory Properties of ciMSC-Derived Extracellular Vesicles Through Adenosine Signaling Pathway
Favorite
12:30 – 14:30
CET
(427) Enhancement of WNT pathway-related genes following treatment with microRNA-31-loaded extracellular vesicles in an inflammatory bowel disease-mimicking organoid model
Favorite
12:30 – 14:30
CET
(428) Engineered Extracellular Vesicles a Next Generation Therapeutic Delivery Platform
Favorite
12:30 – 14:30
CET
(429) Inclusion of recombinant proteins into extracellular vesicles by Lactococcus cremoris
Favorite
12:30 – 14:30
CET
(430) Engineered extracellular vesicles for therapeutic CRISPR-Cas9 delivery
Favorite
12:30 – 14:30
CET
(431) A comparative study of different approaches employed in the functionalization of the EVs surface with hyaluronic acid derivatives
Favorite
12:30 – 14:30
CET
(432) Tumor cell cytotoxicity of NK cell-derived exosomes labeled with tumor-targeting peptide and pro-apoptotic peptide
Favorite
12:30 – 14:30
CET
(433) A Novel Controllable Loading and Releasing Strategy in EV-mediated Delivery
Favorite
12:30 – 14:30
CET
(434) Gentle harvesting, purification and labelling of plant extracellular vesicles and their loading with exogenous cargo using a µPulse Tangential Flow Filtration system
Favorite
12:30 – 14:30
CET
(435) Engineering hybrid extracellular vesicles for mRNA delivery
Favorite
12:30 – 14:30
CET
(436) Optimization of red blood cell-derived extracellular vesicles hybrids for therapeutic RNA delivery
Favorite
12:30 – 14:30
CET
(437) Single-particle characterization reveals heterogeneous extracellular vesicle-liposome fusion
Favorite
12:30 – 14:30
CET
(438) Proximity labeling and imaging of extracellular particles using membrane-bound ascorbate peroxidases
Favorite
12:30 – 14:30
CET
(439) Rapid plasma EV isolation and PD-L1 mRNA detection CRISPR-Cas13a-based enzymatic hydrogel chip: immunotherapy outcome prediction
Favorite
12:30 – 14:30
CET
(440) Ultrasensitive and absolute quantification of extracellular vesicles using the PICO digital immunoassay
Favorite
12:30 – 14:30
CET
(441) Extracellular vesicle trafficking in colorectal cancer: a deep learning approach for tracking analysis
Favorite
12:30 – 14:30
CET
(442) Visualization of extracellular vesicle DNA and CD63 in recipient cells using dual-color single-molecule localization microscopy
Favorite
12:30 – 14:30
CET
(443) Glycan mapping of tumor-derived extracellular vesicles: a multiplex lectin bead approach
Favorite
12:30 – 14:30
CET
(444) A comparative study of magnetic bead-based techniques for isolating plasma-derived extracellular vesicles
Favorite
12:30 – 14:30
CET
(445) Detection and characterization of extracellular vesicles from platelet-poor plasma samples using a nanoscale-dedicated CytoFLEX nano Analyzer.
Favorite
12:30 – 14:30
CET
(446) Optimization and challenges of isolation-free single-vesicle measurement in diabetic patient plasma using high-sensitivity flow cytometry
Favorite
12:30 – 14:30
CET
(447) Fluorescence Imaging and qPCR Analysis for Assessing Biodistribution of Extracellular Vesicles
Favorite
12:30 – 14:30
CET
(448) Versatile EV surface modification for selective uptake
Favorite
12:30 – 14:30
CET
(449) Development of an NHS Ester-Based Lipid Staining Method for Small Extracellular Vesicles and Particles Under Low pH Conditions
Favorite
12:30 – 14:30
CET
(450) Spectrally separated dual label upconversion luminescence lateral flow immunoassay for simultaneous detection of CD9+ and CD63+ Extracellular Vesicles
Favorite
12:30 – 14:30
CET
(451) Profiling the biochemical composition of extracellular vesicles in breast cancer using Raman spectroscopy
Favorite
12:30 – 14:30
CET
(452) Optimizing cryopreservation conditions to protect the integrity of red blood cell-derived extracellular vesicles
Favorite
12:30 – 14:30
CET
(454) Construction and Application of a Highly Sensitive Detection Technology for Extracellular Vesicle Membrane Proteins Based on Droplet Microfluidics in the Early Diagnosis of Gastric Cancer
Favorite
12:30 – 14:30
CET
(455) Liquid biopsy-based depression detection and response prediction using EV-SERS-XAI
Favorite
12:30 – 14:30
CET
(456) Microfluidic device to monitor brain tumors using extracellular vesicles from cerebrospinal fluid
Favorite
12:30 – 14:30
CET
(457) In vivo Investigation of Whole Body Biodistribution of Tumor Cell-Derived Exosomes
Favorite
12:30 – 14:30
CET
(458) Fully Integrated Microfluidic Systems for EVs Analysis and Applications to Cancers Identification with AI
Favorite
12:30 – 14:30
CET
(459) Single-molecule protein interaction coupling (PICO) for absolute quantification of intact individual extracellular vesicles protein markers
Favorite
12:30 – 14:30
CET
(460) Study of the properties of modified vesicles as therapeutic vehicles
Favorite
12:30 – 14:30
CET
(461) Heteronuclear MRI of targeted extracellular vesicles
Favorite
12:30 – 14:30
CET
(462) Metabolic glycoengineering based bioorthogonal extracellular vesicle surface engineering for tumor targeting
Favorite
12:30 – 14:30
CET
(463) An automated, high throughput method for genetically engineering and phenotyping yeast extracellular vesicles
Favorite
12:30 – 14:30
CET
(464) Efficient labeling and purification of extracellular vesicles using an aptamer to CD9 and PKH-26 dye for enhanced cellular uptake
Favorite
12:30 – 14:30
CET
(465) Ultra-sensitive detection of breast cancer-derived extracellular vesicles using single molecule array technology: a comparative study of capture strategies
Favorite
12:30 – 14:30
CET
(466) Optimizing downstream processing of enveloped virus-like particles and extracellular vesicles using fluorescently labeled particles
Favorite
12:30 – 14:30
CET
(467) A reporter system to study adipocyte-derived extracellular vesicles in vivo
Favorite
12:30 – 14:30
CET
(468) Small RNA-sequencing (miND) enables discovery of EV-specific microRNA signatures that to support EV drug development
Favorite
12:30 – 14:30
CET
(469) Measuring the dynamics of RNA cargo invasion from breast cancer extracellular vesicles on immune cells
Favorite
12:30 – 14:30
CET
(470) Endothelial cells-derived extracellular vesicles as future drug delivery systems – from bioreactor production to in vitro label-free uptake visualization
Favorite
12:30 – 14:30
CET
(471) Nanobody based biomarker detection on individual extracellular vesicles using the capture-EVQuant assay
Favorite
12:30 – 14:30
CET
(472) A Fed-Batch Chemically Defined hMSC-EV Bioprocess Medium Enabling 2-4x EV Yield Improvements in Bioreactor Culture
Favorite
12:30 – 14:30
CET
(473) Development of chemistry, manufacturing and control (CMC) framework for bioengineered extracellular vesicles derived from HEK293T for phase I clinical trial in oncology
Favorite
12:30 – 14:30
CET
(474) A canonical targeted approach to detect and purify exosomes for standardized diagnostic workflows
Favorite
12:30 – 14:30
CET
(475) Selective enrichment of tumor-derived extracellular vesicles by targeting oncofetal chondroitin sulfate using antibody fragments
Favorite
12:30 – 14:30
CET
(476) Lab-on-chip technologies for extracellular vesicle enrichment and detection
Favorite
12:30 – 14:30
CET
(477) Improved EV isolation and analysis using multimodal SEC and enhanced chemiluminescent ELISA
Favorite
12:30 – 14:30
CET
(478) Impact of Culture Media and Size-based Sorting Methods on Extracellular Particle Subpopulations
Favorite
12:30 – 14:30
CET
(479) Evaluation of 12 extracellular vesicle (EV) isolation methods with focus on proteome composition, reproducibility, yield and size distribution
Favorite
12:30 – 14:30
CET
(480) Characterization of EV from Synovial Fluid
Favorite
12:30 – 14:30
CET
(481) Enrichment and quantitation of small platelet-derived extracellular vesicle subpopulations with field-flow fractionation
Favorite
12:30 – 14:30
CET
(482) Evaluation of a novel magnetic bead-based method for isolation of intact EVs or EV-RNA
Favorite
12:30 – 14:30
CET
(483) Extracellular Vesicle and Nanovectors Production, Engineering, and Characterization for Therapy and Diagnosis
Favorite
12:30 – 14:30
CET
(484) Methods for EV Enrichment Workflow Characterization
Favorite
12:30 – 14:30
CET
(485) Advancing Extracellular Vesicle Research: An Integrated Suite for High-Purity Isolation, Standardized Quantification, and Single-Vesicle Biomarker Detection
Favorite
12:30 – 14:30
CET
(486) A Novel Aptamer-Based Approach for Lipoprotein Removal to Achieve Ultra-Pure Blood EV Isolation
Favorite
12:30 – 14:30
CET
(487) Probiotic-derived engineered extracellular vesicles as delivery vehicles for health-promoting xenometabolites
Favorite
12:30 – 14:30
CET
(488) Platelet-free plasma does not (yet) exist
Favorite
12:30 – 14:30
CET
(489) An integrated microfluidic device for neutrophil extracellular vesicles analysis and gastric cancer diagnosis
Favorite
12:30 – 14:30
CET
(490) Develoment of a single reagent for sequential separation and detection of extracellular vesicles from complex biological fluids
Favorite
12:30 – 14:30
CET
(491) EV-Zone: AI-enhanced platform for standardized reporting and advanced literature search in EV research
Favorite
12:30 – 14:30
CET
(492) Study and validation of the metabolic signature of extracellular vesicles as a prognostic and predictive marker in pancreatic cancer
Favorite
12:30 – 14:30
CET
(493) Scalable, high-throughput isolation of extracellular vesicles using electrokinetic-assisted mesh filtration
Favorite
12:30 – 14:30
CET
(494) Rapid and high-yield recovery of plasma-derived extracellular vesicles using modified chromatography with soluble protein depletion for biomarker discovery
Favorite
12:30 – 14:30
CET
(495) Development of tissue-derived EV enrichment from body fluids
Favorite
12:30 – 14:30
CET
(496) EVring: a new platform enabling isolation-free enrichment and size fractionation of extracellular vesicles for enhanced clinical analysis
Favorite
12:30 – 14:30
CET
(497) Crafting clarity on synergy between clinical samples preparation and extracellular vesicles biomarker analysis for metastatic prostate cancer precision care
Favorite
12:30 – 14:30
CET
(498) Multi-instrumental analysis of extracellular vesicle (EV) heterogeneity – experience of the Centre for Applied Nanomedicine (CAN)
Favorite
12:30 – 14:30
CET
(499) Helping development of new projects on extracellular vesicles through a dedicated core facility at Institut Curie
Favorite
12:30 – 14:30
CET
(500) Proteomic profiling of breast cancer cells and their secreted extracellular vesicles upon drug treatment
Favorite
12:30 – 14:30
CET
(501) Size-specific isolation and profiling of extracellular vesicles to create an atlas of their cargo in prostate cancer
Favorite
12:30 – 14:30
CET
(502) Concentrating and purifying extracellular vesicles by suberabsorbent polymers and size exclusion chromatography
Favorite
12:30 – 14:30
CET
(503) Different tetraspanine profile according to biofluid and kidney disease
Favorite
12:30 – 14:30
CET
(504) Engineering extracellular vesicles to transiently permeabilize the blood-brain barrier
Favorite
12:30 – 14:30
CET
(505) Optimising immunocapture of extracellular vesicles from cerebrospinal fluid for biomarker discovery in neurodegenerative diseases
Favorite
12:30 – 14:30
CET
(506) Brain targeting using novel Extracellular Vesicles (EVs)
Favorite
12:30 – 14:30
CET
(507) Enhancing Extracellular Vesicle Characterization through High-Resolution Mass Spectrometry: Development of an R Package and Testing with Public Plasma Datasets
Favorite
12:30 – 14:30
CET
(508) Efficient Isolation of Extracellular Vesicles from Human Plasma Using Droplet Microfluidics
Favorite
12:30 – 14:30
CET
(509) Towards analysis of exogenous siRNA loading homogeneity of bovine milk extracellular vesicles
Favorite
12:30 – 14:30
CET
(510) The Importance of Established and Optimized Analytical Capabilities to Develop End to End and Scalable Therapeutic Extracellular Vesicles Processing
Favorite
12:30 – 14:30
CET
(511) Acidic pH-based elution of extracellular vesicles from magnetic beads
Favorite
12:30 – 14:30
CET
(512) A microdevice for isolation and quantitation of cardiomyocyte-secreted extracellular vesicles and monitoring their secretion profile in cardiac differentiation
Favorite
12:30 – 14:30
CET
(513) Nanoscale detection of EpCAM-positive extracellular vesicles using magnetic beads and interferometric scattering microscopy
Favorite
12:30 – 14:30
CET
(514) Comparative extracellular vesicle purity assessment of independent isolation approaches
Favorite
12:30 – 14:30
CET
(515) ATR-FTIR as a tool for process control during EV isolation
Favorite
12:30 – 14:30
CET
(516) Multiplexed Immunomagnetic Microfluidic Chip for Isolation and Detection of HER2-Positive Exosomes
Favorite
12:30 – 14:30
CET
(517) Pre-analytical considerations to augment signal-to-noise ratio in EV flow cytometry
Favorite
12:30 – 14:30
CET
(518) Size-exclusion chromatography and centrifugation protocols to enrich human plasma EVs: protocol optimization ahead of human clinical sample analyses
Favorite
12:30 – 14:30
CET
(519) Comparative analysis of methods for the purification of extracellular vesicle suspensions from human mesenchymal stem cell culture
Favorite
12:30 – 14:30
CET
(520) Development of a reporter protein for dynamic labeling of cell type-specific extracellular vesicles
Favorite
12:30 – 14:30
CET
(522) Filter-aided extracellular vesicle enrichment (FAEVEr) using 300 kDa MWCO 96-well plates for high-throughput proteomics
Favorite
12:30 – 14:30
CET
(523) Use of advanced aptamer technology in Affinity purification of EV from biological fluids
Favorite
12:30 – 14:30
CET
(524) Targeted proteome analysis of extracellular vesicles from gastric cancer cell lines
Favorite
12:30 – 14:30
CET
(525) Fully-automated cultivation of iMSCs and purification of iMSC-EVs using the AutoCRAT system
Favorite
12:30 – 14:30
CET
(526) Development of a novel EV purification and cargo transfection method for efficient gene delivery
Favorite
12:30 – 14:30
CET
(527) Physicochemical characterization and uptake of EVs isolated via tangential flow filtration, anion exchange- and size exclusion chromatography
Favorite
12:30 – 14:30
CET
(528) Leveraging an antiviral peptide for the targeted disruption of tumor-derived exosomes to enhance cancer immunotherapy
Favorite
12:30 – 14:30
CET
(529) A new class of universal reference EVs expressing horseradish peroxidase (HRP)
Favorite
12:30 – 14:30
CET
(530) Development of a disease-specific analytical reference material for EV-based biomarker study
Favorite
12:30 – 14:30
CET
(531) Development of a novel reference material for the flow cytometry analysis of extracellular vesicles
Favorite
12:30 – 14:30
CET
(532) Customizable liposomes as standardized fluorescent calibrators for submicron extracellular vesicle analysis by flow cytometry
Favorite
12:30 – 14:30
CET
(533) EVCA – Advancing excellence in multidisciplinary research and fostering long-lasting collaborations in extracellular vesicles leading institutions
Favorite
12:30 – 14:30
CET
(534) The dynamin inhibitor, Dynasore, modulates longitudinal bone growth in a two-phased dose-dependent manner
Favorite
12:30 – 14:30
CET
(536) Determining the smallest detectable particle diameter of sizing techniques
Favorite
12:30 – 14:30
CET
(537) Label-free Technology to Assess Protein Loadings on the Surface of Biological Sample
Favorite
12:30 – 14:30
CET
(538) Comparative analysis of the CytoFLEX nano Flow Cytometer and the CytoFLEX LX Flow Cytometer
Favorite
12:30 – 14:30
CET
(539) Label-free Characterization of Biological Nanoparticles
Favorite
12:30 – 14:30
CET
(541) Nanochannel microscopy for single extracellular vesicle analysis
Favorite
12:30 – 14:30
CET
(542) Size-based profiling of single small EVs in Silicon Nanochannels
Favorite
12:30 – 14:30
CET
(543) Single EV charge characterization using nanochannel fluorescence microscopy
Favorite
12:30 – 14:30
CET
(544) A comparative analysis of reproducible EV size and concentration measurement using nanoscale flow cytometry and fluorescent microfluidic resistive pulse sensing
Favorite
12:30 – 14:30
CET
(545) Characterisation of biological nanoparticles using Dual-Angle Interferometric Scattering microscopY (DAISY)
Favorite
12:30 – 14:30
CET
(546) A comparison of flow cytometry technologies for extracellular vesicle analysis
Favorite
12:30 – 14:30
CET
(547) An optimized flow cytometry method for single extracellular vesicle subtyping, count and isolation
Favorite
12:30 – 14:30
CET
(548) Isolation- and bias-free optofluidic platform for single extracellular vesicle characterization
Favorite
12:30 – 14:30
CET
(549) Integrating Interferometric Nanoparticle Tracking Analysis (iNTA) with Fluorescence Detection for Single-Molecule Precision in Distinguishing Nanoparticle Sub-Populations
Favorite
12:30 – 14:30
CET
(550) Particle Detection and Classification Strategies in Cryo Electron Microscopy Images of Purified Cancer Cell Derived Extracellular Vesicles
Favorite
12:30 – 14:30
CET
(551) New microfluidic technology allows detection and high throughput sorting of single fluorescent extracellular vesicles
Favorite
12:30 – 14:30
CET
(552) Sample concentration and background signals impact single EV analysis by high-sensitivity flow cytometry: a comparison across three different generation platforms
Favorite
12:30 – 14:30
CET
(553) Evaluation of methods for removing free fluorescent antibodies to optimize the characterization of EV surface proteins
Favorite
12:30 – 14:30
CET
(554) Advancements in MESF Beads for Enhanced Fluorescence Quantification in Flow Cytometry
Favorite
12:30 – 14:30
CET
(555) High-resolution characterization of HIV and extracellular vesicles by STORM-FISHing: combining dSTORM and smFISH
Favorite
12:30 – 14:30
CET
(556) Electrochemical biosensor for extracelular vesicle biomarker quantification with very low limits of detection
Favorite
12:30 – 14:30
CET
(557) Tradeoffs for Rapid NTA Measurements
Favorite
12:30 – 14:30
CET
(558) Three dimensional (3D) cultured umbilical cord MSC-derived extracellular vesicles (EV) mitigate kidney damage in chronic kidney disease (CKD) models
Favorite
12:30 – 14:30
CET
(559) Deletion of the tissue factor-coding F3 gene ameliorates thrombogenic adverse effects of extracellular vesicles in human and rat blood
Favorite
12:30 – 14:30
CET
(560) Small Extracellular Vesicle-Driven Ferroptosis: A Novel Strategy to Target Therapy-Resistant Ovarian Cancer
Favorite
12:30 – 14:30
CET
(561) Impact of genetic modification of microRNA cargo in human induced pluripotent stem cell- derived extracellular vesicles on their pro-regenerative activity in ischemic tissues
Favorite
12:30 – 14:30
CET
(562) The impact of bovine milk extracellular vesicles on the gut: Insights from human intestinal epithelial organoid models
Favorite
12:30 – 14:30
CET
(563) Exploring the role of plant-derived nanovesicles in regulating mitochondrial activity during skin inflammation
Favorite
12:30 – 14:30
CET
(564) EVs secreted by pro-oncogenic and anti-tumor neutrophils modulate the angiogenesis proces.
Favorite
12:30 – 14:30
CET
(565) Comparative proteomic analyses of 2D and spheroid U87 Glioblastoma-derived extracellular vesicles in response to temozolomide: potential protein biomarker insights
Favorite
12:30 – 14:30
CET
(566) Combinational therapy for the treatment of ischemic stroke
Favorite
12:30 – 14:30
CET
(567) The impact of sympathetic nerve-derived EVs on metastatic potential in breast cancer: the role of EMT-related microRNAs
Favorite
12:30 – 14:30
CET
(568) Long non-coding H19 transported by colorectal cancer derived small extracellular vesicles promotes alternative splicing in healthy hepatocytes: new insights on the liver pre-metastatic niche formation
Favorite
12:30 – 14:30
CET
(569) Proteomic profiling of tumor-draining vein-derived extracellular vesicles reveals novel prognostic biomarkers in lung adenocarcinoma
Favorite
12:30 – 14:30
CET
(570) Human healthy liver spheroid as model to study the role of colorectal cancer derived small extracellular vesicles in priming the hepatic pre-metastatic niche
Favorite
12:30 – 14:30
CET
(572) The influence of melanoma extracellular vesicles on the vascular endothelium microenvironment
Favorite
12:30 – 14:30
CET
(573) An Investigation of the Effect of Hypoxia on Extracellular Vesicles Released From Triple Negative Breast Cancer Cell Lines
Favorite
12:30 – 14:30
CET
(574) Chemotherapy induced painful peripheral neuropathy alters Schwann cell derived extracellular vesicles isolated from mouse peripheral nerves
Favorite
12:30 – 14:30
CET
(575) Exosomes and Hair Disorder
Favorite
12:30 – 14:30
CET
(576) Plasma Extracellular Vesicles Regulated the Function of ILC2s via miRNA-150-5p in Patients with Allergic Rhinitis
Favorite
12:30 – 14:30
CET
(577) Calcium ionophore enhances the release of neutrophil-derived extracellular vesicles with therapeutic potential for sepsis
Favorite
12:30 – 14:30
CET
(578) The microRNAs contained in extracellular vesicles derived from foam cells promote atherosclerosis in cells around plaques.
Favorite
12:30 – 14:30
CET
(580) Topically applied engineered ASC-derived exosomes decrease inflammation and stimulate tissue repair mechanisms that provide treatment for intractable eczema
Favorite
12:30 – 14:30
CET
(581) Engineered pro-healing EV cargo targeting chronic wounds by manipulating the cellular environment in a closed-system bioreactor
Favorite
12:30 – 14:30
CET
(582) Engineering Yulangsan-derived extracellular vesicles can target the treatment of ischemic stroke through anti-inflammatory and anti-apoptotic pathways
Favorite
12:30 – 14:30
CET
(583) Extracellular vesicle-associated heparan sulphate proteoglycans drive prostate cancer growth and have potential application as biomarkers of clinically significant disease
Favorite
12:30 – 14:30
CET
(584) Identifying extracellular vesicle-based biomarkers distinguishing responders from non-responders in EndoBARR clinical trial patients
Favorite
12:30 – 14:30
CET
(585) Higher percentages of CD221 (IGF-1 receptor)-positive EVs detected by bead-based and single-EV flow cytometry in blood from breast cancer survivors: preliminary results during lifestyle intervention
Favorite
12:30 – 14:30
CET
(586) TP53 isoform proteins and mRNAs in extracellular vesicles: potential biomarkers for colorectal cancer detection
Favorite
12:30 – 14:30
CET
(587) Extracellular vesicle-encapsulated microRNA_9985 inhibits lung adenocarcinoma growth by targeting GCC2
Favorite
12:30 – 14:30
CET
(588) Identification of miRNAs associated with immunotherapy response in mouse pancreatic cancer
Favorite
12:30 – 14:30
CET
(589) From Glioblastoma to the Blood: Tenascin-C positive EVs as clinical biomarkers and vehicles of circulating tumor DNA
Favorite
12:30 – 14:30
CET
(590) EVs in liquid biopsies: do different size exclusion chromatography approaches yield different results?
Favorite
12:30 – 14:30
CET
(591) Glycosylation profiling of small extracellular vesicles in head and neck squamous cell carcinoma reveals potential biomarkers
Favorite
12:30 – 14:30
CET
(592) Extracellular vesicles as activity-based biomarkers: a novel, versatile approach to analyze EV-associated protease activity
Favorite
12:30 – 14:30
CET
(593) Enhancement of Extracellular Vesicles production for personalised medicine
Favorite
12:30 – 14:30
CET
(594) Extracellular vesicles derived from clonally-expanded immortalized mesenchymal stromal cells reduce neuro-inflammation in pre-clinical sepsis
Favorite
12:30 – 14:30
CET
(595) Red blood cell-derived extracellular vesicles as alternative vehicles of anti-fibrotic miRNA mimics and their effect in in vitro models of liver fibrosis
Favorite
12:30 – 14:30
CET
(597) Extracellular vesicles to fight dementia: a journey across the blood-brain barrier
Favorite
12:30 – 14:30
CET
(598) Targeted Migration of Milk-Derived Exosomes to Brain Inflammation Sites: Implications for Neurological Therapeutics
Favorite
12:30 – 14:30
CET
(599) Harnessing Collagen Binding Separates Two Functionally Distinct Subpopulation of Milk Extracellular Vesicles regarding Bone Regeneration
Favorite
12:30 – 14:30
CET
(600) Leveraging extracellular vesicles for enhanced imaging: insights from preclinical research
Favorite
12:30 – 14:30
CET
(601) Mycobacterial EVs from different strains as potential tuberculosis vaccine candidates
Favorite
12:30 – 14:30
CET
(602) Extracellular Vesicles from Plasma of Patients with Gastric Cancer Modulate T Cell Immune Phenotype
Favorite
12:30 – 14:30
CET
(603) Artemisiae scopariae Herba derived extracellular vesicle-like particles confers anti-inflammatory effects in liver injury via regulating IL-17 signaling pathways
Favorite
12:30 – 14:30
CET
(604) Plant-Derived Extracellular Vesicles Ameliorate aGVHD after allo-HSCT by Inhibiting NLRP3 Inflammatory Vesicle Activation
Favorite
